8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2016 / Randomized controlled trial
In the Bath Breakfast Project, 23 obese adults were randomly assigned to daily breakfast (≥700 kcal before 1100) or extended fasting (0 kcal until 1200) for 6 weeks under free-living conditions. Breakfast resulted in greater physical activity thermogenesis during the morning (difference: 188 kcal/d; 95% CI: 40, 335), but without a consistent effect over 24 hours. Energy intake was not significantly greater with breakfast (difference: 338 kcal/d; 95% CI: -313, 988). Body mass increased across both groups over time with no treatment effects on body composition or resting metabolic rate, while daily breakfast was associated with a reduced insulinemic response to an oral-glucose-tolerance test relative to an increase with fasting (P = 0.05).
Chowdhury EA, Richardson JD, Holman GD, et al. Am J Clin Nutr, 2016. PMID 26864365
2016 / Randomized crossover trial
A randomized crossover pilot trial evaluated 26 adults with type 2 diabetes who consumed 1,200 mg of aged garlic extract or placebo daily for 4 weeks. Supplementation had no significant effect on insulin resistance or metabolic measures. In addition, aged garlic extract did not significantly alter markers of endothelial function, oxidative stress, or vascular inflammation in this high-risk population.
Atkin M, Laight D, Cummings MH J Diabetes Complications, 2016. PMID 26954484
2016 / Randomized controlled trial
In an open-label trial with 50 adults having non-alcoholic fatty liver disease, participants received either lifestyle changes alone or with 30 grams daily of milled flaxseed for 12 weeks. Both groups improved, but flaxseed produced greater reductions in ALT (-11.12 vs -3.7 U/L), AST (-8.29 vs -4 U/L), GGT (-15.7 vs -2.62 U/L), fibrosis (-1.26 vs -0.77 kPa), and steatosis (-47 vs -15.45 dB/m). Body weight and insulin resistance also decreased more with flaxseed.
Yari Z, Rahimlou M, Eslamparast T, et al. Int J Food Sci Nutr, 2016. PMID 26983396
2016 / Randomized crossover trial
In a randomized crossover study, healthy young adults consumed evening meals of whole grain rye kernel bread (RKB) or white wheat bread (WWB) as either a single meal or across three consecutive evenings. Compared to WWB, the RKB evening meal decreased blood glucose (0-120 min, P = 0.001), serum insulin response (0-120 min, P < 0.05), and fasting free fatty acids (P < 0.05) the next morning. RKB also increased plasma PYY (0-120 min, P < 0.001), GLP-1 (0-90 min, P < 0.05), fasting acetate and butyrate (P < 0.05), breath hydrogen excretion (P < 0.001), and improved subjective appetite ratings (P < 0.05). With the exception of serum CRP, length of priming did not significantly alter outcomes.
Sandberg JC, Björck IM, Nilsson AC PLoS One, 2016. PMID 26990559
2016 / Clinical trial
Thirty adults with type 2 diabetes followed an eight-week very low-calorie diet before returning to an isocaloric maintenance plan. Body weight dropped from 98.0 ± 2.6 to 83.8 ± 2.4 kg and remained stable at 84.7 ± 2.5 kg at six months. Fasting blood glucose normalized below 7 mmol/L in 12 participants after refeeding and in 13 participants at six months, accompanied by recovered first-phase insulin response.
Steven S, Hollingsworth KG, Al-Mrabeh A, et al. Diabetes Care, 2016. PMID 27002059
2016 / Randomized placebo-controlled trial
Researchers evaluated a four-ingredient nutritional mixture (GSK2890457) in rodent models and a six-week randomized trial with healthy participants and adults with type 2 diabetes. In diabetic participants taking liraglutide, the supplement did not lower weight and produced slight decreases in mean glucose and HbA1c compared to placebo. In those taking metformin, weight increased by 1.26%, while mean glucose and HbA1c were decreased slightly versus placebo.
Hodge RJ, Paulik MA, Walker A, et al. PLoS One, 2016. PMID 27093610
2016 / Double-blind, placebo-controlled, balanced crossover trial
In a balanced crossover trial, 36 adults with type 2 diabetes consumed single doses of synthetic trans-resveratrol (0, 75, 150, and 300 mg) at weekly intervals. CVR to a hypercapnic stimulus was assessed by transcranial Doppler ultrasound before and 45 minutes after treatment. Resveratrol increased CVR in the middle cerebral arteries, with mean within-individual changes from placebo of 13.8 ± 3.5% for 75 mg (P = 0.001), 8.9 ± 3.5% for 150 mg (P = 0.016), and 13.7 ± 3.3% for 300 mg (P < 0.001). Only the 75 mg dose significantly increased CVR in the posterior cerebral arteries (13.2 ± 4.5%, P = 0.016).
Wong RH, Nealon RS, Scholey A, et al. Nutr Metab Cardiovasc Dis, 2016. PMID 27105868
2016 / Randomized, double-blind, placebo-controlled clinical trial
A randomized, double-blind, placebo-controlled pilot trial assigned 44 patients with NAFLD to receive either 2 grams per day of a ginger supplement or an identical placebo for 12 weeks, with both groups advised to follow a modified diet and physical activity program. Compared to placebo, ginger supplementation led to significant reductions in alanine aminotransferase, γ-glutamyl transferase, inflammatory cytokines, insulin resistance index, and hepatic steatosis grade. No significant effect was found on hepatic fibrosis or aspartate aminotransferase.
Rahimlou M, Yari Z, Hekmatdoost A, et al. Hepat Mon, 2016. PMID 27110262
2016 / Randomized controlled trial
A randomized trial assigned 44 patients with metabolic syndrome to lifestyle advice alone or with 30 grams of milled flaxseed daily. Metabolic syndrome rates dropped by 82% in the flaxseed group compared to 50% in controls. The flaxseed group experienced greater reductions in insulin resistance (p < 0.001), body weight, waist circumference, and body mass index, although blood pressure showed no significant alterations.
Yari Z, Rahimlou M, Poustchi H, et al. Phytother Res, 2016. PMID 27151322
2016 / Randomized controlled trial
Nineteen healthy adults completed a 4-day inpatient protocol under dim light conditions and were randomized to 3 hours of blue-enriched light exposure either 0.5 hours after waking (n=9) or 10.5 hours after waking (n=10) on Day 3, with Day 2 serving as baseline. In both groups, insulin total area, HOMA-IR, and HOMA-IR AUC were increased, and subjective sleepiness was reduced with blue-enriched light compared to dim light. The evening group, but not the morning group, exhibited a significantly higher peak glucose value during blue-enriched light exposure compared to dim light. There were no other significant differences between morning and evening groups in response to blue-enriched light.
Cheung IN, Zee PC, Shalman D, et al. PLoS One, 2016. PMID 27191727
2016 / Retrospective analysis of a dietary intervention study
Researchers retrospectively analyzed data from 37 adults with metabolic syndrome who consumed 100 g of white button mushrooms daily for 16 weeks, followed by a one-month mushroom-free period. At 16 weeks, participants showed a doubling of serum ergothioneine, increases in ORAC and adiponectin, and significant decreases in carboxymethyllysine (CML) and methylglyoxal (MG). No changes were observed in 8-isoprostane, leptin, or measures of insulin resistance or glucose metabolism. The authors noted that well-controlled studies are needed to confirm these findings.
Calvo MS, Mehrotra A, Beelman RB, et al. Plant Foods Hum Nutr, 2016. PMID 27193019
2016 / Randomized controlled trial
In two randomized controlled trials, 55 overweight and obese adults consumed test meals containing varying mycoprotein amounts (44 g, 88 g, or 132 g) or isoenergetic chicken. High mycoprotein decreased subsequent ad libitum energy intake by 10% (280 kJ / 67 kcal, P=0.009) relative to chicken. All mycoprotein meals reduced postprandial insulin concentrations (incremental AUC drops of 8%, 12%, and 21%, P=0.004), without altering glucose, GLP-1, PYY, or energy expenditure.
Bottin JH, Swann JR, Cropp E, et al. Br J Nutr, 2016. PMID 27198187
2016 / Randomized controlled trial
Participants with type 2 diabetes were randomly assigned to follow either a vegan diet (n = 46) or a conventional diet recommended by the Korean Diabetes Association 2011 (n = 47) for 12 weeks. Both groups experienced significant reductions in HbA1c, but reductions were larger in the vegan group than in the conventional group (-0.5% vs. -0.2%; p-for-interaction = 0.017). Among participants with high compliance, the reduction difference between groups was larger (-0.9% vs. -0.3%), remaining significant after adjusting for changes in total energy intake or waist circumference. The authors noted that further studies are needed to evaluate the long-term effects of a vegan diet.
Lee YM, Kim SA, Lee IK, et al. PLoS One, 2016. PMID 27253526
2016 / Randomized controlled trial and animal study
A randomized controlled trial in humans demonstrated that a moderate protein-restricted diet improved markers of metabolic health. In parallel animal experiments, mice provided a diet specifically low in branched-chain amino acids showed improvements in glucose tolerance and body composition comparable to whole protein restriction. These changes operated through distinct metabolic pathways, indicating that dietary amino acid composition directly influences metabolic function.
Fontana L, Cummings NE, Arriola Apelo SI, et al. Cell Rep, 2016. PMID 27346343
2016 / Intervention study (mice and humans)
Investigators studied the effects of dietary protein dilution (DPD) on metabolic health markers in mice and humans, as well as its mechanistic pathways in murine models. DPD increased serum markers of metabolic health in both mice and humans. In lean mice, DPD promoted metabolic inefficiency by increasing carbohydrate and fat oxidation, and in murine models of obesity, it prevented and curtailed impaired glucose homeostasis independently of obesity and food intake. The metabolic improvements required liver-derived FGF21, induced by liver-integrated stress response-driven NUPR1 triggered by insufficiency of select nonessential amino acids.
Maida A, Zota A, Sjøberg KA, et al. J Clin Invest, 2016. PMID 27548521
2016 / Randomized controlled trial
A randomized pilot trial assigned 26 adults with obesity to 8 weeks of zero-calorie alternate-day fasting or daily calorie restriction (-400 kcal/day). Weight loss did not differ significantly between groups at 8 weeks (-8.2 ± 0.9 kg for fasting vs -7.1 ± 1.0 kg for restriction), nor were there differences in lipids, body composition, or insulin sensitivity. After 24 weeks of unsupervised follow-up, weight regain was similar between groups.
Catenacci VA, Pan Z, Ostendorf D, et al. Obesity (Silver Spring), 2016. PMID 27569118
2016 / Randomized controlled trial
In a 12-week trial of 80 overweight and obese women in a weight-loss program, 69 completed allocating their main energy intake to lunch or dinner. The lunch group achieved greater reductions in weight (-5.85 kg vs. -4.35 kg; P = 0.003), body mass index (P = 0.003), fasting insulin (P < 0.001), and insulin resistance (P = 0.001) than the dinner group. Fasting glucose and lipid profiles did not differ between groups.
Madjd A, Taylor MA, Delavari A, et al. Am J Clin Nutr, 2016. PMID 27581472
2016 / Clinical trial
A clinical trial examined postmenopausal women with obesity undergoing approximately 10% weight loss on hypocaloric diets containing either 0.8 g or 1.2 g protein/kg/day. The higher-protein diet reduced lean tissue loss by roughly 45%. However, higher protein intake also eliminated the weight-loss-induced gains in muscle insulin signaling and insulin-stimulated glucose uptake, while preventing cellular adaptations in oxidative stress pathways.
Smith GI, Yoshino J, Kelly SC, et al. Cell Rep, 2016. PMID 27732859
2016 / Comparative clinical trial
Systemic inflammation was assessed three months after gastric bypass (n=15) or a very low-calorie diet (n=12) in morbidly obese women with type 2 diabetes, plus 12 lean controls. Both interventions lowered CRP and leptin while raising adiponectin. However, the diet was linked to reductions in TNF-alpha, IL-2, and IL-6, whereas bypass was linked to increased TNF-alpha and higher numbers of activated cytotoxic T and B cells.
Lips MA, van Klinken JB, Pijl H, et al. Metabolism, 2016. PMID 27733249
2016 / Randomized crossover trial series
Researchers evaluated high-calorie diets enriched with saturated fatty acids (SFA) or carbohydrates (CARB) compared to a standard eucaloric AHA control diet in subjects with NGT or IGT. Steady state plasma glucose (SSPG) increased by 83±74% versus control after a 24-hour SFA diet across the entire cohort (n=38; NGT: 92±82%, n=22; IGT: 65±55%, n=16; all p<0.001) and by 55±32% after a single SFA breakfast (p=0.008, n=7). The SSPG elevation was 24±31% after an overnight fast (p=0.04, n=10) and further attenuated 24 hours after returning to the control diet (19±35%, p=0.09, n=11), while a 24-hour CARB diet did not significantly increase SSPG (26±50%, p=0.11, n=12).
Koska J, Ozias MK, Deer J, et al. Metabolism, 2016. PMID 27733250
2016 / Randomised crossover study
A randomised crossover study evaluated 41 adults with type 2 diabetes mellitus comparing advice to walk 30 minutes each day versus advice to walk 10 minutes after each main meal for 2-week periods. Postprandial glycaemia iAUC over 3 hours post-meal was significantly lower when walking after meals compared with a single daily walk (ratio of geometric means 0.88, 95% CI 0.78, 0.99). The improvement was especially marked after the evening meal (0.78, 95% CI 0.67, 0.91), when carbohydrate consumption was highest. One participant died during the 30-day washout period, an event not judged to be related to study participation.
Reynolds AN, Mann JI, Williams S, et al. Diabetologia, 2016. PMID 27747394
2016 / Open, parallel, randomized study
A 12-week open parallel randomized study compared a vegetarian diet to a conventional diet, both with the same caloric restriction (-500 kcal/day), alongside supervised aerobic exercise in 74 patients with type 2 diabetes. All meals were provided for the entire study duration. VO2max increased by 12% in the vegetarian group (p < 0.001) with no significant change in the conventional group (p = 0.667; group x time p = 0.004). Maximal performance (Watt max) increased by 21% in the vegetarian group (p < 0.001) but did not change in the conventional group (p = 0.334; group x time p = 0.048).
Veleba J, Matoulek M, Hill M, et al. Nutrients, 2016. PMID 27792174
2016 / Randomized, double-blind, placebo-controlled, crossover trial
In a randomized, double-blind, placebo-controlled crossover trial, 42 Japanese subjects consumed placebo or kale-containing food (7 g active-L or 14 g active-H) with a high-carbohydrate meal. Maximum plasma glucose concentrations (Cmax) were significantly lower for active-L (163±24 mg/dl) and active-H (162±23 mg/dl) compared with placebo (176±26 mg/dl; P<0.01). Glucose AUC0-2 h was also significantly lower for active-L (268±43 mg/h/dl) and active-H (266±42 mg/h/dl) versus placebo (284±43 mg/h/dl; P<0.05). No significant differences were found in postprandial plasma insulin levels, and no adverse events were observed.
Kondo S, Suzuki A, Kurokawa M, et al. Biomed Rep, 2016. PMID 27882216
2016 / Randomized, double-blind, controlled clinical trial
Sixty patients with Alzheimer's disease were randomized to receive 200 ml/day of control milk or probiotic milk containing Lactobacillus acidophilus, L. casei, Bifidobacterium bifidum, and L. fermentum for 12 weeks. Compared to controls (-5.03% ± 3.00), the probiotic group showed a significant improvement in MMSE scores (+27.90% ± 8.07, P < 0.001). Probiotic intake also led to significant favorable changes in plasma malondialdehyde, serum hs-CRP, HOMA-IR, beta cell function, serum triglycerides, and QUICKI compared with control (all P < 0.01). No considerable effects were observed on fasting plasma glucose, other lipid profiles, or other biomarkers of oxidative stress and inflammation.
NANO counterpoint →
Akbari E, Asemi Z, Daneshvar Kakhaki R, et al. Front Aging Neurosci, 2016. PMID 27891089